BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 29547831)

  • 1. Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents.
    Pal M; Nandi U; Mukherjee D
    Eur J Med Chem; 2018 Apr; 150():419-445. PubMed ID: 29547831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, X-ray structure, physicochemical properties and anticancer activity of mer and fac Ru(iii) triphenylphosphine complexes with a benzothiazole derivative as a co-ligand.
    Richert M; Walczyk M; Cieślak MJ; Kaźmierczak-Barańska J; Królewska-Golińska K; Wrzeszcz G; Muzioł T; Biniak S
    Dalton Trans; 2019 Jul; 48(28):10689-10702. PubMed ID: 31241117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetically labile ruthenium(II) complexes of terpyridines and saccharin: effect of substituents on photoactivity, solvation kinetics, and photocytotoxicity.
    Kumar P; Singh P; Saren S; Pakira S; Sivakumar S; Patra AK
    Dalton Trans; 2021 Jun; 50(23):8196-8217. PubMed ID: 34031678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic Ruthenium(II) Complexes Containing a Dangling Pyridine: Selectivity for Diseased Cells Mediated by pH-Dependent DNA Binding.
    Sangeetha S; Murali M
    Inorg Chem; 2022 Feb; 61(6):2864-2882. PubMed ID: 35099196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
    Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
    Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, structural characterization, in vitro DNA binding, and antitumor activity properties of Ru(II) compounds containing 2(2,6-dimethoxypyridine-3-yl)-1H-imidazo(4,5-f)[1, 10]phenanthroline.
    Chintakuntla N; Putta VR; Mallepally RR; K N; Vuradi RK; Kotha LR; Singh SS; Sirasani S
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(5):760-791. PubMed ID: 31983278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ru
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
    Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
    Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazole appended quinoline-BODIPY based arene ruthenium complexes: their anticancer activity and potential applications in cellular imaging.
    Paitandi RP; Sharma V; Singh VD; Dwivedi BK; Mobin SM; Pandey DS
    Dalton Trans; 2018 Dec; 47(48):17500-17514. PubMed ID: 30507985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the antibacterial and anticancer potential of tryptamine based mixed ligand Schiff base Ruthenium(III) complexes.
    Malik MA; Raza MK; Dar OA; Amadudin ; Abid M; Wani MY; Al-Bogami AS; Hashmi AA
    Bioorg Chem; 2019 Jun; 87():773-782. PubMed ID: 30974300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
    Notaro A; Gasser G
    Chem Soc Rev; 2017 Nov; 46(23):7317-7337. PubMed ID: 29027562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
    Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q
    Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos.
    Golbaghi G; Pitard I; Lucas M; Haghdoost MM; de Los Santos YL; Doucet N; Patten SA; Sanderson JT; Castonguay A
    Eur J Med Chem; 2020 Feb; 188():112030. PubMed ID: 31945643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells.
    Tian M; Li J; Zhang S; Guo L; He X; Kong D; Zhang H; Liu Z
    Chem Commun (Camb); 2017 Nov; 53(95):12810-12813. PubMed ID: 29143019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luminescent naphthalimide-tagged ruthenium(ii)-arene complexes: cellular imaging, photocytotoxicity and transferrin binding.
    Srivastava P; Verma M; Kumar A; Srivastava P; Mishra R; Sivakumar S; Patra AK
    Dalton Trans; 2021 Mar; 50(10):3629-3640. PubMed ID: 33625414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Class of Half-Sandwich Ruthenium(II) Arene Complexes Bearing the Water-Soluble CAP Ligand as an in Vitro Anticancer Agent.
    Guerriero A; Oberhauser W; Riedel T; Peruzzini M; Dyson PJ; Gonsalvi L
    Inorg Chem; 2017 May; 56(10):5514-5518. PubMed ID: 28443659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifunctional ruthenium(ii) polypyridyl complexes of curcumin as potential anticancer agents.
    Li S; Xu G; Zhu Y; Zhao J; Gou S
    Dalton Trans; 2020 Jul; 49(27):9454-9463. PubMed ID: 32598409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ruthenium(II)-polypyridyl complex inhibits cell proliferation and induces cell apoptosis by impairing DNA damage repair.
    Yang Q; Zhang Z; Mei W; Sun F
    J Chemother; 2014 Aug; 26(4):235-42. PubMed ID: 24070188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.